To better understand the communication difficulties experienced by autistic adults and help the clinicians and researchers who have autistic people in their lives, researchers from Drexel University’s A.J. Drexel Autism Institute reviewed recent research on the subject and crafted a set of recommendations.  

Researchers have long been able to use information from smartwatches to identify physical movement, such as sitting or walking, that wearers are performing in a controlled lab setting. Now, Washington State University researchers have developed a way, using a computer algorithm and a large dataset gathered from smartwatches, to more comprehensively identify what people are doing in everyday settings, such as working, eating, doing hobbies or running errands.

Many different mutational signatures, or "fingerprints" of DNA damage have been identified across different tumor types which can provide a record of environmental exposure or clues about the etiology of carcinogenesis. Most of the mutational signature characterization has been performed using tumors from American and European populations due to the availability of sequencing data in these regions from large-scale atlases such as The Cancer Genome Atlas and the International Cancer Genome Consortium. While some unique mutational signatures have been identified in various Asian populations, mutational signatures and their activity in tumors from Chinese patients have not been well characterized across cancer types.

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by researchers led by Radboud university medical center in a study published in The Lancet Digital Health. The use of AI could reduce workload and save millions of euros annually.

People who have had COVID-19 are at increased risk of developing certain inflammatory diseases of the airways, such as asthma, hay fever and chronic sinusitis. However, vaccination against the SARS-CoV-2 virus appears to reduce the risk, according to a comprehensive epidemiological study led by researchers at Karolinska Institutet.